Canada Generic and Biosimilar Pharmaceutical Market Analysis

Canada Generic and Biosimilar Pharmaceutical Market Analysis


$ 3999

Canada Generic and Biosimilar Pharmaceutical Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The generic and biosimilar pharmaceutical market is driven by cost-effectiveness, patent expirations, rising healthcare demand, and government cost-cutting initiatives. Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz International GmbH (Novartis), Pfizer Inc., Amgen Inc., Biocon Ltd., Dr. Reddy's Laboratories Ltd., Fresenius Kabi AG, Celltrion Inc., and Stada Arzneimittel AG are global companies in the Generic and Biosimilar Pharmaceutical Market.

ID: IN10CAPH284 CATEGORY: Pharmaceuticals GEOGRAPHY: Canada AUTHOR: Riddhi Solanki

Buy Now

Canada Generic and Biosimilar Pharmaceutical Market Analysis Summary

Canada Generic and Biosimilar Pharmaceutical Market is valued at around $44714 Mn in 2022 and is projected to reach $63587.9 Mn by 2030, exhibiting a CAGR of 4.5% during the forecast period 2023-2030.

Cost-effectiveness, patent expirations, rising healthcare demand, and government cost-cutting initiatives are all driving factors in the generic and biosimilar pharmaceutical business. Global participants in the Generic and Biosimilar Pharmaceutical Market include Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz International GmbH (Novartis), Pfizer Inc., Amgen Inc., Biocon Ltd., Dr. Reddy's Laboratories Ltd., Fresenius Kabi AG, Celltrion Inc., and Stada Arzneimittel AG are global companies in the Generic and Biosimilar Pharmaceutical Market.

Market Dynamics

Market Growth Drivers

  1. Cost-effectiveness: Generic and biosimilar pharmaceuticals are frequently less expensive than their branded counterparts, making them an appealing alternative for healthcare systems and patients alike
  2. Patent expirations: When branded medicine patents expire, it allows generic and biosimilar producers to enter the market and offer alternatives
  3. Increasing healthcare demand: The rising prevalence of chronic diseases, combined with an aging population, has increased demand for pharmaceutical products such as generics and biosimilars
  4. Government initiatives: To lower healthcare costs and enhance access to important treatments, many governments throughout the world are pushing the use of generic and biosimilar drugs

Market Restraints

  1. Regulatory issues: The clearance procedure for biosimilars is complex and strict, requiring significant comparability studies and clinical trials that can be time-consuming and expensive
  2. Concerns about intellectual property: Concerns about patent litigation and intellectual property protection can stymie the expansion of the generic and biosimilar medication markets
  3. Manufacturing complexities: Because biosimilars are complicated biological medications, specialized manufacturing techniques are required, making their production more difficult than standard generic drugs

Competitive Landscape

Key Players

  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Sandoz International GmbH (Novartis)
  • Pfizer Inc.
  • Amgen Inc.
  • Biocon Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Fresenius Kabi AG
  • Celltrion Inc.
  • Stada Arzneimittel AG 

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Canada Generic and Biosimilar Pharmaceutical Market Segmentation

By Product Type

  • Generic Small Molecules
  • Biosimilars
  • Generic Biologics

By Application

  • Oncology
  • Autoimmune Diseases
  • Diabetes
  • Cardiovascular Diseases
  • Others

By Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
  • Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.​

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

  • Analyzing historical proprietary data collected from multiple projects.
  • Regularly updating our existing data sets with new findings and trends.
  • Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

  • Searching through academic conferences, published research, citations, and social media platforms
  • Collecting and compiling diverse data to build a comprehensive and detailed database
  • Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

  • Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
  • Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
  • Continuously refreshing our database to ensure that the information remains current and reliable.
  • Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

  • Merging historical data from secondary research with real-time data from primary research.
  • Conducting thorough data validation and cleansing to remove inconsistencies and errors.
  • Organizing data into a structured format that is easily accessible and usable for various applications.
  • Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


Last updated on: 27 February 2024
Updated by: Ritu Baliya

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up